Clinical Trial

Transcriptional and Epigenetic Program of PCOS Women

Study acronym: EPIC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main goal is to reveal differences in global gene expression in two different adipose tissue (AT) depots of females with and without polycystic ovary syndrome (PCOS) and how these are influenced by upstream epigenetic markers
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2019-07-24; most recent amendment 2025-03-12.
Status change: Recruiting → Active, Not Recruiting 2023-07-21
Status change: Not Yet Recruiting → Recruiting 2020-03-09
Trial Details
NCT Number NCT04034706
Lead Sponsor AdventHealth Translational Research Institute
Conditions PCOS
Enrollment 108 participants
Start Date 2020-01-31
Primary Completion 2023-04-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-13